DiaMedica Gets a 15% Lift in Share Price

DiaMedica Gets a 15% Lift in Share Price
Share this article

DiaMedica_Inc. (TSX-V:DMA) saw some activity in the stock today as it jumped over 15% on above average trading volume finally landing at $0.38 cents at closing. The Company is focused on developing novel treatments for vascular diseases, including stroke and metabolic and kidney dysfunction. Although there was no news out today, the Company did recently announce that the US Patent Office issued a patent for the DiaMedica’s Human Tissue Kallikrein 1 Glycosylation Isoforms, which cover the composition of matter of the Company’s product candidate.

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.